Superoxide dismutase and hippocampal function: Age and isozyme matter

Antioxidants and Redox Signaling

Volumn 9, Issue 2, 2007, Pages 201-210

  Hu, Daoying ^a   Klann, Eric ^a,c   Thiels, Edda ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; MANGANESE DERIVATIVE; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AGE; AGING; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; LEARNING; LIFESPAN; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ANTIOXIDANTS; HIPPOCAMPUS; LEARNING; LONG-TERM POTENTIATION; MEMORY; MICE; MICE, TRANSGENIC; NEURONAL PLASTICITY; OXIDATION-REDUCTION; PROTEIN ISOFORMS; SUPEROXIDE DISMUTASE; SUPEROXIDES; SYNAPSES;

ANIMALIA; MUS MUSCULUS;

EID: 33846197940     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.9.201     Document Type: Review

References (83)

1. Albers DS and Beal MF. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm Suppl 59: 133-154, 2000.
2. Auerbach JM and Segal M. Peroxide modulation of slow onset potentiation in rat hippocampus. J Neurosci 17: 8695-8701, 1997.
3. Balaban RS, Nemoto S, and Finkel T. Mitochondria, oxidants, and aging. Cell 120: 483-495, 2005.
4. Barnes CA. Long-term potentiation and the ageing brain. Philos Trans R Soc Lond B Biol Sci 358: 765-772, 2003.
5. Bar-Peled O, Korkotian E, Segal M, and Groner Y. Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons. Proc Natl Acad Sci USA 93: 8530-8535, 1996.
6. Beni SM, Tsenter J, Alexandrovich AG, Galron-Krool N, Barzilai A, Kohen R, Grigoriadis N, Simeonidou C, and Shohami E. CuZn-SOD deficiency, rather than overexpression, is associated with enhanced recovery and attenuated activation of NF-kappaB after brain trauma in mice. J Cereb Blood Flow Metab 26: 478-490, 2006.
7. Berlett BS and Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272: 20313-20316, 1997.
8. Bindokas VP, Jordan J, Lee CC, and Miller RJ. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 16: 1324-1336, 1996.
9. Bliss TV and Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39, 1993.
10. Brooksbank BW and Balazs R. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Brain Res 318: 37-44, 1984.
11. Cai JG, Ren GR, and Jiang GR. Clinical and experimental studies of jianyi oral liquid in improving learning and memory of the aged. Zhongguo Zhong Xi Yi Jie He Za Zhi 14: 203-206, 195, 1994.
12. Callio J, Oury TD, and Chu CT. Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains. J Biol Chem 280: 18536-18542, 2005.
13. Ceballos-Picot I, Nicole A, Briand P, Grimber G, Delacourte A, Defossez A, Javoy-Agid F, Lafon M, Blouin JL, and Sinet PM. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res 552: 198-214, 1991.
14. Chan PH, Epstein CJ, Li Y, Huang TT, Carlson E, Kinouchi H, Yang G, Kamii H, Mikawa S, Kondo T, et al. Transgenic mice and knockout mutants in the study of oxidative stress in brain injury. J Neurotrauma 12: 815-824, 1995.
15. Chance B, Sies H, and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605, 1979.
16. Chen Z, Siu B, Ho YS, Vincent R, Chua CC, Hamdy RC, and Chua BH. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol 30: 2281-2289, 1998.
17. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
18. Esposito F, Ammendola R, Faraonio R, Russo T, and Cimino F. Redox control of signal transduction, gene expression and cellular senescence. Neurochem Res 29: 617-628, 2004.
19. Esposito L, Raber J, Kekonius L, Yan F, Yu GQ, Bien-Ly N, Puolivali J, Scearce-Levie K, Masliah E, and Mucke L. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 26: 5167-5179, 2006.
20. Finkel T and Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247, 2000.
21. Forman HJ, Torres M, and Fukuto J. Redox signaling. Mol Cell Biochem 234-235: 49-62, 2002.
22. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 64: 97-112, 1995.
23. Fukagawa NK. Aging: is oxidative stress a marker or is it causal? Proc Soc Exp Biol Med 222: 293-298, 1999.
24. Fullerton HJ, Ditelberg JS, Chen SF, Sarco DP, Chan PH, Epstein CJ, and Ferriero DM. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol 44: 357-364, 1998.
25. Gahtan E, Auerbach JM, Groner Y, and Segal M. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur J Neurosci 10: 538-544, 1998.
26. Gould TJ and Feiro OR. Age-related deficits in the retention of memories for cued fear conditioning are reversed by galantamine treatment. Behav Brain Res 165: 160-171, 2005.
27. Gromov LA, Seredi PI, Syrovatskaia LP, Ovinova Gy and Filonenko MA. [Free radical mechanisms of memory disorders of toxic origin and experimental therapy of the condition]. Patol Fiziol Eksp Ter: 24-26, 1993.
28. Halliwell B. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Acta Neurol Scand Suppl 126: 23-33, 1989.
29. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 59: 1609-1623, 1992.
30. Harman D. Alzheimer's disease: role of aging in pathogenesis. Ann NY Acad Sci 959: 384-395; discussion 463-385, 2002.
31. Harris-Cerruti C, Kamsler A, Kaplan B, Lamb B, Segal M, and Groner Y. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein [correction]. Eur J Neurosci 19: 1174-1190, 2004.
32. Ho YS, Vincent R, Dey MS, Slot JW, and Crapo JD. Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol 18: 538-547, 1998.
33. Hu D, Serrano F, Oury TD, and Klann E. Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. J Neurosci 26: 3933-3941, 2006.
34. Iannello RC, Crack PJ, de Haan JB, and Kola I. Oxidative stress and neural dysfunction in Down syndrome. J Neural Transm Suppl 57: 257-267, 1999.
35. Kamsler A and Segal M. Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity. Mol Neurobiol 29: 167-178, 2004.
36. Kamsler A and Segal M. Hydrogen peroxide modulation of synaptic plasticity. J Neurosci 23: 269-276, 2003.
37. Kamsler A and Segal M. Paradoxical actions of hydrogen peroxide on long-term potentiation in transgenic superoxide dismutase-1 mice. J Neurosci 23: 10359-10367, 2003.
38. Kanterewicz BI, Knapp LT, and Klann E. Stimulation of p42 and p44 mitogen-activated protein kinases by reactive oxygen species and nitric oxide in hippocampus. J Neurochem 70: 1009-1016, 1998.
39. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, and Mattson MP. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18: 687-697, 1998.
40. Klann E. Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. J Neurophysiol 80: 452-457, 1998.
41. Klann E and Thiels E. Modulation of protein kinases and protein phosphatases by reactive oxygen species: implications for hippocampal synaptic plasticity. Prog Neuropsychopharmacol Biol Psychiatry 23: 359-376, 1999.
42. Knapp LT and Klann E. Role of reactive oxygen species in hippocampal long-term potentiation: contributory or inhibitory? J Neurosci Res 70: 1-7, 2002.
43. Kokoszka JE, Coskun P, Esposito LA, and Wallace DC. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci USA 98: 2278-2283, 2001.
44. Levin ED, Brady TC, Hochrein EC, Oury TD, Jonsson LM, Marklund SL, and Crapo JD. Molecular manipulations of extracellular superoxide dismutase: functional importance for learning. Behav Genet 28: 381-390, 1998.
45. Levin ED, Bracato FH, and Crapo JD. Molecular overexpression of extracellular superoxide dismutase increases the dependency of learning and memory performance on motivational state. Behav Genet 30: 95-100, 2000.
46. Levin ED, Christopher NC, and Crapo JD. Memory decline of aging reduced by extracellular superoxide dismutase overexpression. Behav Genet 35: 447-453, 2005.
47. Levin ED, Christopher NC, Lateef S, Elamir BM, Patel M, Liang LP, and Crapo JD. Extracellular superoxide dismutase overexpression protects against aging-induced cognitive impairment in mice. Behav Genet 32: 119-125, 2002.
48. Levkovitz Y, Avignone E, Groner Y, and Segal M. Upregulation of GABA neurotransmission suppresses hippocampal excitability and prevents long-term potentiation in transgenic superoxide dismutase-overexpressing mice. J Neurosci 19: 10977-10984, 1999.
49. Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B, and Baudry M. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci USA 100: 8526-8531, 2003.
50. Maier CM and Chan PH. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8: 323-334, 2002.
51. Malenka RC and Nicoll RA. Long-term potentiation - a decade of progress? Science 285: 1870-1874, 1999.
52. Maragos WF, Jakel R, Chesnut D, Pocernich CB, Butterfield DA, St Clair D, and Cass WA. Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Brain Res 878: 218-222, 2000.
53. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 222: 649-655, 1984.
54. Martindale JL and Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1-15, 2002.
55. Melov S, Doctrow SR, Schneider JA, Haberson J, Patel M, Coskun PE, Huffman K, Wallace DC, and Malfroy B. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci 21: 8348-8353, 2001.
56. Milton NG. Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment. Drugs Aging 21: 81-100, 2004.
57. Multhaup G, Ruppert T, Schlicksupp A, Hesse L, Beher D, Masters CL, and Beyreuther K. Reactive oxygen species and Alzheimer's disease. Biochem Pharmacol 54: 533-539, 1997.
58. Muscoli C, Cuzzocrea S, Riley DP, Zweier JL, Thiemermann C, Wang ZQ, and Salvemini D. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br J Pharmacol 140: 445-460, 2003.
59. Oberley TD, Coursin DB, Cihla HP, Oberley LW, el-Sayyad N, and Ho YS. Immunolocalization of manganese superoxide dismutase in normal and transgenic mice expressing the human enzyme. Histochem J 25: 267-279, 1993.
60. Oler JA and Markus EJ. Age-related deficits on the radial maze and in fear conditioning: hippocampal processing and consolidation. Hippocampus 8: 402-415, 1998.
61. Ookawara T, Imazeki N, Matsubara O, Kizaki T, Oh-Ishi S, Nakao C, Sato Y, and Ohno H. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am J Physiol 275: C840-847, 1998.
62. Oury TD, Card JP, and Klann E. Localization of extracellular superoxide dismutase in adult mouse brain. Brain Res 850: 96-103, 1999.
63. Oury TD, Chang LY, Marklund SL, Day BJ, and Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest 70: 889-898, 1994.
64. Peluffo H, Acarin L, Aris A, Gonzalez P, Villaverde A, Castellano B, and Gonzalez B. Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector. BMC Neurosci 7: 35, 2006.
65. Petersen SV, Oury TD, Valnickova Z, Thogersen IB, Hojrup P, Crapo JD, and Enghild JJ. The dual nature of human extracellular superoxide dismutase: one sequence and two structures. Proc Natl Acad Sci USA 100: 13875-13880, 2003.
66. Pineda JA, Aono M, Sheng H, Lynch J, Wellons JC, Laskowitz DT, Pearlstein RD, Bowler R, Crapo J, and Warner DS. Extracellular superoxide dismutase overexpression improves behavioral outcome from closed head injury in the mouse. J Neurotrauma 18: 625-634, 2001.
67. Pratico D. Lipid peroxidation and the aging process. Sci Aging Knowledge Environ 2002: re5, 2002.
68. Roberson ED, English JD, and Sweatt JD. A biochemist's view of long-term potentiation. Learn Mem 3: 1-24, 1996.
69. Schuessel K, Schafer S, Bayer TA, Czech C, Pradier L, Muller-Spahn F, Muller WE, and Eckert A. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol Dis 18: 89-99, 2005.
70. Serrano F and Klann E. Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res Rev 3: 431-443, 2004.
71. Shin JH, London J, Le Pecheur M, Hoger H, Pollak D, and Lubec G. Aberrant neuronal and mitochondrial proteins in hippocampus of transgenic mice overexpressing human Cu/Zn superoxide dismutase 1. Free Radic Biol Med 37: 643-653, 2004.
72. Staniek K and Nohl H. Are mitochondria a permanent source of reactive oxygen species? Biochim Biophys Acta 1460: 268-275, 2000.
73. Stone JR and Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8: 243-270, 2006.
74. St-Pierre J, Buckingham JA, Roebuck SJ, and Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 277: 44784-44790, 2002.
75. Sweatt JD. Hippocampal function in cognition. Psychopharmacology (Berl) 174: 99-110, 2004.
76. Thiels E and Klann E. Hippocampal memory and plasticity in superoxide dismutase mutant mice. Physiol Behav 77: 601-605, 2002.
77. Thiels E, Urban NN, Gonzalez-Burgos GR, Kanterewicz BI, Barrionuevo G, Chu CT, Oury TD, and Klann E. Impairment of long-term potentiation and associative memory in mice that overexpress extracellular superoxide dismutase. J Neurosci 20: 7631-7639, 2000.
78. Warner DS, Sheng H, and Batinic-Haberle I. Oxidants, antioxidants and the ischemic brain. J Exp Biol 207: 3221-3231, 2004.
79. Watson JB, Khorasani H, Persson A, Huang KP, Huang FL, and O'Dell TJ. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin- dependent protein kinase II. J Neurosci Res 70: 298-308, 2002.
80. Xing J, Yu Y, and Rando TA. The modulation of cellular susceptibility to oxidative stress: protective and destructive actions of Cu,Zn-superoxide dismutase. Neurobiol Dis 10: 234-246, 2002.
81. Yen HC, Oberley TD, Vichitbandha S, Ho YS, and St Clair DK. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 98: 1253-1260, 1996.
82. Zeevalk GD, Bernard LP, Song C, Gluck M, and Ehrhart J. Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration. Antioxid Redox Signal 7: 1117-1139, 2005.
83. Zhang S, Liu J, and He L. Anisodamine (654-2) improves impaired cognitive function induced by experimental brain damage. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 17: 254-258, 1995.